Objective: Patients with head and neck cancer undergoing surgery have a high incidence of postoperative complications. The aim of our study was to investigate whether postoperative nutrition of head and neck cancer patients, using an arginineenriched diet, could improve nutritional variables as well as clinical outcomes. Design: Randomized clinical trial. Setting: Tertiary care. Subjects: A population of 47 patients with oral and laryngeal cancer were enrolled. Interventions: At surgery patients were randomly allocated to two groups: (a) patients receiving an enteral diet supplemented with arginine and fiber (group I); (b) patients receiving an isocaloric, isonitrogenous enteral formula (group II). Results: No significant intergroup differences in the trend of the three plasma proteins and lymphocytes were detected. Gastrointestinal tolerance (diarrhea) of both formulas was good (17.4% group I and 8.3% group II; NS). During the 3 months after hospital discharge five patients died; no diferences were detected between groups (13% group I and 8.3% group II; NS). The incidences postoperative infection complications were similar (nine patients) in both groups (21.7% group I and 16.7% group II; NS). Fistula were less frequent in enriched nutrition group (0% group I and 20.8% group II; P < 0.05); wound infection was more frequent in group II, but without statistical difference (4.3% group I and 12.5% group II; NS). The length of postoperative stay was 22.8 AE 11.8 days in the enriched group and 31.2 AE 19.1 days in the control group (P ¼ 0.07). Conclusions: In conclusion, enriched formula improves local wound complications in postoperative head and neck cancer patients. Our results suggest that these patients could benefit from an immunonutrient-enhanced enteral formula.
Introduction
Patients with head and neck cancer undergoing surgery have a high incidence of postoperative complications (Arriaga et al, 1990) . These complications include anastomotic fistula, wound infection and major complications such as septicemia, and may lead to a prolonged hospital stay.
It is known that the immune system is frequently affected in these patients. Also, surgery and malnutrition (which is frequent in these patients) have been found to depress the immune system (Van Bokhorst-de van der Schueren et al, 1998) .
Alterations in the host defense mechanisms make patients susceptible to complications. Although immune dysfunction could be multifactorial, the immune system may be modulated by specific nutritional substrates, such as arginine (Daly et al, 1998) . There is evidence suggesting that enteral nutrition, supplemented with different agents including arginine and dietary fiber, improves immune function and reduces postoperative complications, in different groups of patients, such as those undergoing pancreatic surgery , surgery for stomach and colo-rectum cancer (Gianoti et al, 1999; Wu et al, 2001) , and critically ill patients (Caparros et al, 2001 ).
The aim of our study was to investigate whether postoperative nutrition of head and neck cancer patients, using an immunonutrition diet, could improve nutritional variables as well as clinical outcomes, postoperative infections, wound complications and length of stay, when compared with an isonitrogenous, isocaloric control enteral diet.
Material and methods

Patients
A population of 47 patients with oral and laryngeal cancer was enrolled. Exclusion criteria included: severely impaired hepatic function (total bilirubin concentration > 3.5 mg=dl) and renal function (serum creatinine concentration > 2.5 mg=dl); ongoing infections; autoimmune disorders; steroid treatment; nutritional oral supplementation in the previous 6 months; and severe malnourishment (weight loss >10% of body weight). The study was a prospective randomized trial carried out from March 1999 to July 2001. Baseline studies on all patients consisted of taking a complete history and physical examination. General assessment of nutritional status included measurements of height, body weight and body mass index (BMI; kg=m 2 ).
Nutrition
At surgery patients were randomly allocated to two groups: (a) patients receiving an enteral diet supplemented with arginine and dietary fiber (group I); (b) patients receiving an isocaloric, isonitrogenous enteral formula (group II). The main investigator and patients remained blind to the treatment group. Table 1 shows the composition of the two enteral diets. Enteral feeding was started within 24 h of surgery at a rate of 20 ml=h, via an intraoperatively placed nasogastric tube. The infusion rate was progressively increased every 24 h until the daily nutritional goal (32 total kcal=kg; 1.7 g protein=kg) was reached, on postoperative day 4. All patients reached 100% of calculated requirements. Any drop-outs were present in the study. The endpoint for nutritional support was a minimum oral intake of 1500 cal= day and 1 g=kg=day of protein without supplementation with a minimun of 10 days of enteral support. Prophylactic antibiotic treatment was given for 7 days postoperatively (ceftazidime, 500 mg three times daily i.v. and clyndamicine 300 mg three times daily i.v.).
Patient monitoring
Perioperatively and on postoperative days 7 and 14 the following parameters were evaluated: serum values of prealbumin (mg=dl), transferrin (mg=dl), albumin (g=dl) and total number of lymphocytes (10 6 =ml). Postoperative complications were recorded as none, general infections (respiratory tract infection was diagnosed when the chest radiograhic examination showed new or progressive unfiltration, temperature above 38.5 C and isolation of pathogens from the sputum or blood culture and=or urinary tract infection was diagnosed if the urine culture showed at least 10 5 colonies of a pathogen) and local complications such as fistula and=or wound infection, assessing all complications using standard methods and the same investigator. Gastrointestinal problems related to enteral feeding were also recorded (diarrhea, > 5 liquid stools in a 24 h period or an estimated volume > 2000 ml=day). Mortality was assessed 3 months after hospital discharge.
Assays
Fasting blood samples were drawn for measurement of albumin (3.5 -4.5 g=dl), prealbumin (18 -28 mg=dl), transferrin (250 -350 mg=dl), and lymphocytes (1.2 -3.5.10 3 =ml) with an autoanalyzer (Hitachi, ATM, Manheim, Germany).
Statistical analysis
Sample size was calculated to decrease fistula complication by 20% with 80% power and 5% significance. The results were expressed as average AE standard deviation. The distribution of variables was analyzed with a Kolmogorov -Smirnov test. Quantitative variables with normal distribution were analyzed with two-tailed paired or unpaired Student's t-test, as needed, and analysis of variance (ANOVA). Non-parametric variables were analyzed with the Friedman and Wilcoxon tests. To minimize the potential for introducing bias, all randomized patients were included in the comparisons, irrespective of whether or not and for how long they complied with their allocated regimen (intention-to-treat analysis). A P-value < 0.05 was considered statistically significant.
Results
Forty-seven patients were enrolled in the study. The mean age was 61.4 AE 11.7 y (five females=42 males). There were 23 patients in group I (supplemented diet) and 24 patients in the control diet group II. Characteristics of the patients on enrollment were similar for the two groups, reflecting the Table 3 , no significant intergroup differences in the trends of the three plasma proteins and lymphocytes were detected. No differences were detected in weight.
Gastrointestinal tolerance (diarrhea) of both formulas was good, with no intergroup differences (17.4% group I and 8.3% group II; NS). There were no dropouts due to intolerance.
During the 3 months after hospital discharge, five patients died; no diferences were detected between groups (13% group I and 8.3% group II; NS). The postoperative infection complications (urinary tract and pneumonia with similar distribution) were similar (nine patients) in both groups (21.7% group I and 16.7% group II; NS). Statistical differences were detected in local complications: fistula diagnosed by X-ray was less frequent in enriched nutrition group (0% group I and 20.8% group II; P < 0.05); frequency of wound infection was higher in group II, without statistical difference (4.3% group I and 12.5% group II; NS)
The length of postoperative stay was 22.8 AE 11.8 days in the immunonutrition group and 31.2 AE 19.1 days in the control group (P ¼ 0.07), within the limit of statistical difference.
Discussion
Malnutrition and immunosuppression were two characteristics of head and neck cancer patients (Riboli et al, 1996) . Malnutrition is reported in 50% of these patients (Bassett & Dobie, 1990) . Malnutrition is due to reduced dietary intake secondary to dysphagia and alcohol consumption (Reilly, 1990) ; interleukins secreted by the tumor with a catabolic action played a dominant role (Todorov et al, 1996) . Immunosupression is related to surgery and the immunosuppressive capacity of the tumor (Katz, 1983) . For example, Van Bokhorst-de van der Schueren has recently reported that head and neck cancer patients with weight loss exceeding 10% during the 6 months before surgery are at great risk of the occurrence of major complications (Van Bokhorst-de van der Schueren et al, 1997).
However, only a few studies have analyzed the immunonutrition formula with arginine or dietary fiber used in our study. Riso et al (2000) confirmed that an enteral diet supplemented with arginine in the early postoperative period improved postoperative immunological status and speeded up recovery from the immunodepression following surgical trauma. In the malnourished patients of this study, administration of an enriched formula reduced major postoperative complications and length of postoperative stay significantly. In our study, length of stay was shorter in the enriched formula group, but the difference was not statistically significant; however wound complications (fistula) were also improved in our patients. Snyderman et al (1999) with a perioperative nutritional supplementation with an immune-enhancing formula was superior to standard formula in the prevention of postoperative infectious complications. There was no significant difference in wound healing problems or duration of hospitalization. Higher albumin serum was demonstrated in the enriched formula group compared with standard formula. Caparros et al (2001) showed in critically ill patients with a diet enriched with arginine and fiber, a decrease in catheter-related sepsis rate. In our study with better nourished patients than those reported in previous studies, no differences were detected in postoperative infection complications, but wound complications were lower and plasma proteins improved with standard and immune-enhancing formula; we do not have a Arginine stimulates anabolic hormone release, improves survival in gut-derived sepsis and peritonitis by modulating bacterial clearance, and has been demonstrated to enhance natural killer cell cytotoxicity, increase T-cell proliferation, and accelerate wound healing (Reynolds et al, 1988) . Fibersupplemented enteral formulas may have a beneficial effect on components of the gut barrier, as well as the gut mucosa, and on bacterial translocation (Cummings, 1983) . Insoluble fiber, rich in cellulose and lignin, can exert beneficial effects by increasing fecal mass through water absorption, thereby regulating intestinal transit and decreasing the incidence of constipation and diarrhea. Soluble fiber is degraded by anaerobic colonic flora forming short-chain fatty acids, with a trophic effect on the mucosa of the large bowel.
In conclusion, the enriched formula improves local wound complications in postoperative head and neck cancer patients. Our results suggest that these patients could benefit from an arginine-and fiber-enhanced enteral formula.
